| Expression of c-erbB-2 oncoprotein in transitional cell bladder cancer. | bladder, |
| Estrogen and progesterone receptor and c-erbB-2 oncoprotein analysis in pure in situ breast carcinoma: an immunohistochemical study. | breast, |
| Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene. | breast, |
| Induction of epithelial abnormalities that resemble human breast lesions by the expression of the neu/erbB-2 oncogene in reconstituted mouse mammary gland. | breast, |
| An immunohistochemical study of the c-erbB-2 oncogene product in intraductal mucin-hypersecreting neoplasms and in ductal cell carcinomas of the pancreas. | neoplasm, |
| An activated allele of the c-erbB-2 oncogene impairs kidney and lung function and causes early death of transgenic mice. | lung,kidney, |
| Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein. | breast, |
| [Expression of the oncogene Her-2/neu as a prognostic factor in breast cancer]. | breast, |
| c-erbB-2 oncoprotein in screen-detected breast carcinoma: an immunohistological study. | breast, |
| [Aggressive diffuse lymphoma with malignant pleural effusion expressing c-erbB-2 (neu) oncogene products]. | lymphoma, |
| c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer. | breast, |
| Prognostic significance of Helix pomatia lectin and c-erbB-2 oncoprotein in human breast cancer. | breast, |
| The neu-oncogene product in serum and tissue of patients with breast carcinoma. | breast, |
| The product of the c-erbB-2 proto-oncogene as a target for diagnosis and therapy in breast cancer. | breast, |
| Overexpression of HER2/neu oncogene in human pancreatic carcinoma. | pancreatic, |
| Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group. | breast, |
| The relative prognostic significance of total cathepsin D and HER-2/neu oncogene amplification in breast cancer. The South Australian Breast Cancer Study Group. | breast, |
| Expression of retinoblastoma tumor suppressor gene protein, epidermal growth factor receptor, and c-erbB-2 oncoprotein in primary vaginal carcinomas. | retinoblastoma, |
| c-erbB-2 oncoprotein overexpression in uterine cervix carcinoma with glandular differentiation. A frequent event but not an independent prognostic marker because it occurs late in the disease. | uterine, |
| An inbred colony of oncogene transgenic mice: diversity of tumours and potential as a therapeutic model. | colorectal, |